|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
HSP, Common Dominant Evaluation
Test Code93078
CPT Codes
81405 (x2), 81406 (x2), 81479<br><strong>CPT coding may differ dependent on payer rules which may impact prior authorization testing.</strong><br><strong>Please direct any questions regarding CPT coding to the payer being billed.</strong><br><br>This test is not available for New York patient testing<br>Limited Access Code
Physician Attestation of Informed Consent
This germline genetic test requires physician attestation that patient consent has been received if ordering medical facility is located in AK, DE, FL, GA, IA, MA, MN, NV, NJ, NY, OR, SD or VT or test is performed in MA.
Preferred Specimen
8 mL whole blood collected in two EDTA (lavender-top) tubes
Pediatric (0-3 Years): 2 mL
Pediatric (0-3 Years): 2 mL
Minimum Volume
6 mL • Pediatric: 1 mL
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 10 days
Refrigerated: 10 days
Frozen: Unacceptable
Refrigerated: 10 days
Frozen: Unacceptable
Methodology
Next Generation Sequencing
Setup Schedule
Set up: Varies; Report available: 28-42 days
Reference Range
See Laboratory Report
Clinical Significance
This test includes sequencing 4 genes including: ATL1, SPAST, REEP1, KIF5A, and a SPAST deletion test. This test will detect 70-80% of genetic causes of autosomal dominant HSP.